Document and Entity Information
Document and Entity Information | Oct. 06, 2022 |
Cover [Abstract] | |
Amendment Flag | false |
Entity Central Index Key | 0001806952 |
Document Type | 8-K |
Document Period End Date | Oct. 06, 2022 |
Entity Registrant Name | Lyell Immunopharma, Inc. |
Entity Incorporation State Country Code | DE |
Entity File Number | 001-40502 |
Entity Tax Identification Number | 83-1300510 |
Entity Address, Address Line One | 201 Haskins Way |
Entity Address, City or Town | South San Francisco |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 94080 |
City Area Code | 650 |
Local Phone Number | 695-0677 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Common Stock, $0.0001 par value per share |
Trading Symbol | LYEL |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |